Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 5Phase 4 3Phase NA 2Phase EARLY_PHASE1 1Phase 1 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 3Plasma cell 1Head & Neck 1Gastrointestinal 1

Conditions

Venous Thromboembolism 3Upper Extremity Deep Vein Thrombosis 1Thrombosis 1Neoplasms 1Multiple Myeloma 1Head and Neck Neoplasms 1Catheter-Related Infections 1

Interventions

Epoetin Alfa 8ferric carboxymaltose 6epoetin beta 6Meropenem 6Ceftazidime 5Vancomycin 4Darbepoetin alfa 4apixaban 3Enoxaparin 3Ciprofloxacin 3Cefepime 3iron isomaltoside 1000 2ferrous sulfate 2ferrous fumarate 2Teicoplanin 2Radiotherapy 2Levofloxacin 2Filgrastim 2Dalteparin 2Cholecalciferol 2Aspirin 2Amikacin 2sotorasib 1posaconazole 1ferrous succinate 1ferric gluconate 1eltrombopag 1ceftolozane, tazobactam drug combination 1Vitamin B 12 1Vaccination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × apixaban × Classical hematology × Clear all
NCT07189897 2025-10-08

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

State University of New York - Upstate Medical University

Phase 4 Recruiting
76 enrolled
Classical hematologyHead & Neck

Head and Neck Neoplasms, Thrombosis, Venous Thromboembolism

NCT06603870 2025-05-30

STREAM-Line

Ottawa Hospital Research Institute

Phase 4 Recruiting
330 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism, Catheter-Related Infections, Upper Extremity Deep Vein Thrombosis

NCT02958969 2019-12-17

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Dana-Farber Cancer Institute

Phase 4 Completed
50 enrolled 5 charts
Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡